Corgentech announces presentation of 3268 Phase III data at 2006 Pediatric Academic Societies' annual meeting.

(From Chemical Business NewsBase - Press Release)

Corgentech Inc announced that data from a Phase III trial of 3268, a fast-acting local anaesthetic aimed at reducing pain associated with venipunctures and intravenous line placements will be presented during the 2006 Pediatric Academic Societies' annual meeting being held 29 Apr-2 May 2006, at the Moscone Convention Center in San Francisco, CA. Two Phase III studies have shown 3268 to significantly reduce the pain associated with venous access procedures in children. 3268 …